• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Insurers change breast screening rules

Article

Several U.S. insurance companies have changed their guidelines for mammography screening in response to new recommendations from the National Cancer Institute and American Cancer Society that women ages 40 to 49 receive regular screening, according to

Several U.S. insurance companies have changed their guidelines for mammography screening in response to new recommendations from the National Cancer Institute and American Cancer Society that women ages 40 to 49 receive regular screening, according to Amnews, the newspaper of the American Medical Association. The NCI changed its recommendation in March to advocate screening women in the younger age group (SCAN 4/2/97).

Aetna U.S. Healthcare and Anthem Blue Cross/Blue Shield now say they will encourage and pay for screening for women in the younger age group, although individual health plans have some flexibility in implementing the policy. Both companies previously covered regular mammography screening starting at age 50.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.